All subjects who have consented to participate in the study, including those that did not qualify after screening and those that dropped out after consent.
U.S. Food and Drug Administration (FDA). (2019). Guidance for industry: E6(R2) good clinical practice—Integrated addendum to ICH E6(R1). Silver Spring, MD: FDA. https://www.fda.gov/media/93884/download